 |
인쇄하기
취소
|
Court dismisses Dong-A’s collusion over Valtrex
Published: 2012-11-02 06:57:00
Updated: 2012-11-02 06:57:00
The Seoul Higher Court ruled Wednesday that Dong-A Pharm did not collude with GlaxoSmithKline (GSK) over the sales of GSK’s Valtrex (valaciclovir).
Therefore, the court said that the fines imposed by the Fair Trade Commission (FTC) should be revoked over Valtrex, although collusion over GSK’s Zofran (ondansetron) is still recognized.
Both companies pursued legal action against the FTC in ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.